Decreased replication ability of E1-deleted adenoviruses correlates with increased brain tumor malignancy

Cancer Research

Volumn 65, Issue 19, 2005, Pages 8936-8943

  Ghosh, Subrata ^a   Duigou, Gregory J ^a  

^a Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN E1; VIRUS DNA; VIRUS PROTEIN;

ADENOVIRUS; ARTICLE; ASTROCYTOMA CELL; BRAIN CANCER; CANCER CELL CULTURE; CANCER GRADING; CELL CULTURE; CONTROLLED STUDY; CYTOPATHOLOGY; DNA REPLICATION; E1A GENE; E1B GENE; GENE DELETION; GLIOBLASTOMA; GLIOSARCOMA; HUMAN; HUMAN TISSUE; MENINGIOMA; NONHUMAN; PRIORITY JOURNAL; PROGENY; PROTEIN EXPRESSION; VIRUS GENE; VIRUS MUTANT; VIRUS REPLICATION;

ADENOVIRIDAE; ADENOVIRUS E1 PROTEINS; ASTROCYTOMA; BRAIN NEOPLASMS; CELL LINE, TUMOR; CYTOPATHOGENIC EFFECT, VIRAL; DISEASE PROGRESSION; GLIOBLASTOMA; GLIOSARCOMA; HUMANS; MENINGIOMA; VIRUS REPLICATION;

EID: 25444463272     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-05-0581     Document Type: Article

References (56)

1. Vertosick FT, Jr., Selker RG, Arena VC. Survival of patients with well-differentiated astrocytomas diagnosed in the era of computed tomography. Neurosurgery 1991;28:496-501.
2. Ohgaki H, Dessen P, Jourde B, et al. Genetic pathways to glioblastoma: a population-based study. Cancer Res 2004;64:6892-9.
3. Kleihues P, Cavenee WK, editors. WHO classification of tumors: pathology and genetics of tumors of the nervous system. Lyon: IARC Press; 2000.
4. Kleihues P, Louis DN, Scheithauer BW, et al. The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 2002;61:215-25; discussion 26-9.
5. Stewart LA. Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet 2002;359:1011-8.
6. Collins VP. Brain tumours: classification and genes. J Neurol Neurosurg Psychiatry 2004;75 Suppl 2:ii2-11.
7. Ichimura K, Schmidt EE, Goike HM, Collins VP. Human glioblastomas with no alterations of the CDKN2A (p16INK4A, MTS1) and CDK4 genes have frequent mutations of the retinoblastoma gene. Oncogene 1996;13:1065-72.
8. 1-S transition control gene abnormalities. Cancer Res 2000;60:417-24.
9. St George JA. Gene therapy progress and prospects: adenoviral vectors. Gene Ther 2003;10:1135-41.
10. Dobbelstein M. Replicating adenoviruses in cancer therapy. Curr Top Microbiol Immunol 2004;273:291-334.
11. Le Gal La Salle G, Robert JJ, Berrard S, et al. An adenovirus vector for gene transfer into neurons and glia in the brain. Science 1993;259:988-90.
12. Akli S, Caillaud C, Vigne E, et al. Transfer of a foreign gene into the brain using adenovirus vectors. Nat Genet 1993;3:224-8.
13. Danthinne X, Imperiale MJ. Production of first generation adenovirus vectors: a review. Gene Ther 2000;7:1707-14.
14. Nevins JR. Regulation of early adenovirus gene expression. Microbiol Rev 1987;51:419-30.
15. Nevins JR. Control of cellular and viral transcription during adenovirus infection. CRC Crit Rev Biochem 1986;19:307-22.
16. Jones N, Shenk T. An adenovirus type 5 early gene function regulates expression of other early viral genes. Proc Natl Acad Sci U S A 1979;76:3665-9.
17. Nevins JR. Mechanism of activation of early viral transcription by the adenovirus E1A gene product. Cell 1981;26:213-20.
18. van der Vliet PC, Sussenbach JS. An adenovirus type 5 gene function required for initiation of viral DNA replication. Virology 1975;67:415-26.
19. Yamashita T, Green M. Adenovirus DNA replication. I. Requirement for protein synthesis and isolation of nuclear membrane fractions containing newly synthesized viral DNA and proteins. J Virol 1974;14:412-20.
20. Flint SJ, Gonzalez RA. Regulation of mRNA production by the adenoviral E1B 55-kDa and E4 Orf6 proteins. Curr Top Microbiol Immunol 2003;272:287-330.
21. Zantema A, Schrier PI, Davis-Olivier A, van Laar T, Vaessen RT, van der Eb A. Adenovirus serotype determines association and localization of the large E1B tumor antigen with cellular tumor antigen p53 in transformed cells. Mol Cell Biol 1985;5:3084-91.
22. Querido E, Marcellus RC, Lai A, et al. Regulation of p53 levels by the E1B 55-kilodalton protein and E4orf6 in adenovirus-infected cells. J Virol 1997;71:3788-98.
23. Moore M, Horikoshi N, Shenk T. Oncogenic potential of the adenovirus E4orf6 protein. Proc Natl Acad Sci U S A 1996;93:11295-301.
24. Frost E, Williams J. Mapping temperature-sensitive and host-range mutations of adenovirus type 5 by marker rescue. Virology 1978;91:39-50.
25. Glasgow JN, Bauerschmitz GJ, Curiel DT, Hemminki A. Transductional and transcriptional targeting of adenovirus for clinical applications. Curr Gene Ther 2004;4:1-14.
26. Philipson L. Adenovirus assay by the fluorescent cell-counting procedure. Virology 1961;15:263-8.
27. Williams JF. Enhancement of adenovirus plaque formation on HeLa cells by magnesium chloride. J Gen Virol 1970;9:251-5.
28. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual 2nd ed. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press; 1989.
29. Munz PL, Young CSH. Polarity in adenovirus recombination. Virology 1984;135:503-14.
30. Epstein LH, Young CSH. Adenovirus homologous recombination does not require expression of the immediate-early E1a gene. J Virol 1991;65:4475-9.
31. Skog J, Edlund K, Widegren B, Salford LG, Wadell G, Mei YF. Efficient internalization into low-passage glioma cell lines using adenoviruses other than type 5: an approach for improvement of gene delivery to brain tumours. J Gen Virol 2004;85:2627-38.
32. Fuxe J, Liu L, Malin S, Philipson L, Collins VP, Pettersson RF. Expression of the coxsackie and adenovirus receptor in human astrocytic tumors and xenografts. Int J Cancer 2003;103:723-9.
33. Jones N, Shenk T. Isolation of deletion and substitution mutants of adenovirus type 5. Cell 1978;13:181-8.
34. Grodzicker T, Klessig DF. Expression of unselected adenovirus genes in human cells co-transformed with the HSV-1 tk gene and adenovirus 2 DNA. Cell 1980;21:453-63.
35. Imperiale MJ, Kao HT, Feldman LT, Nevins JR, Strickland S. Common control of the heat shock gene and early adenovirus genes: evidence for a cellular E1A-like activity. Mol Cell Biol 1984;4:867-74.
36. Eggerding FA, Pierce WC. Molecular biology of adenovirus type 2 semipermissive infections. I. Viral growth and expression of viral replicative functions during restricted adenovirus infection. Virology 1986;148:97-113.
37. Chen SH, Shine HD, Goodman JC, Grossman RG, Woo SL. Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo. Proc Natl Acad Sci U S A 1994;91:3054-7.
38. Shenk T, Jones N, Colby W, Fowlkes D. Functional analysis of adenovirus-5 host-range deletion mutants defective for transformation of rat embryo cells. Cold Spring Harb Symp Quant Biol 1980;44 Pt 1:367-75.
39. Rainov NG, Ren H. Gene therapy for human malignant brain tumors. Cancer J 2003;9:180-8.
40. Parr MJ, Manome Y, Tanaka T, et al. Tumor-selective transgene expression in vivo mediated by an E2F-responsive adenoviral vector. Nat Med 1997;3:1145-9.
41. Jakubczak JL, Ryan P, Gorziglia M, et al. An oncolytic adenovirus selective for retinoblastoma tumor suppressor protein pathway-defective tumors: dependence on E1A, the E2F-1 promoter, and viral replication for selectivity and efficacy. Cancer Res 2003;63:1490-9.
42. Shenk T, Jones N, Colby W, Fowlkes D. Functional analysis of adenovirus type 5 host range deletion mutants defective for transformation of rat embryo cells. Cold Spring Harbor Symp Quant Biol 1979;1979:367-75.
43. Nevins JR, Ginsberg HS, Blanchard JM, Wilson MC, Darnell JE, Jr. Regulation of the primary expression of the early adenovirus transcription units. J Virol 1979;32:727-33.
44. Flint J, Shenk T. Viral transactivating proteins. Annu Rev Genet 1997;31:177-212.
45. Frisch SM, Mymryk JS. Adenovirus-5 E1A: paradox and paradigm. Nat Rev Mol Cell Biol 2002;3:441-52.
46. Kovesdi I, Reichel R, Nevins JE. Identification of a cellular transcription factor involved in E1A transactivation. Cell 1986;45:219-28.
47. Hardy S, Engel DA, Shenk T. An adenovirus early region 4 gene product is required for induction of the infection-specific form of cellular E2F activity. Genes Dev 1989;3:1062-74.
48. Fang L, Stevens JL, Berk AJ, Swindler KR. Requirement of Sur2 for efficient replication of mouse adenovirus type 1. J Virol 2004;78:12888-900.
49. Wang G, Berk AJ. In vivo association of adenovirus large E1A protein with the human mediator complex in adenovirus-infected and -transformed cells. J Virol 2002;76:9186-93.
50. Fueyo J, Gomez-Manzano C, Yung WK, et al. Suppression of human glioma growth by adenovirus-mediated Rb gene transfer. Neurology 1998;50:1307-15.
51. Chakravarti A, Delaney MA, Noll E, et al. Prognostic and pathologic significance of quantitative protein expression profiling in human gliomas. Clin Cancer Res 2001;7:2387-95.
52. Mollenhauer J, Wiemann S, Scheurlen W et al. DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3-26.1 is deleted in malignant brain tumours. Nat Genet 1997;17:32-9.
53. Mollenhauer J, Muller H, Rollender G, et al. The SRCR/SID region of DMBT1 defines a complex multi-allele system representing the major basis for its variability in cancer. Genes Chromosomes Cancer 2002;35:242-55.
54. Wu W, Kemp BL, Proctor ML, et al. Expression of DMBT1, a candidate tumor suppressor gene, is frequently lost in lung cancer. Cancer Res 1999;59:1846-51.
55. Chernova OB, Hunyadi A, Malaj E, et al. A novel member of the WD-repeat gene family, WDR11, maps to the 10q26 region and is disrupted by a chromosome translocation in human glioblastoma cells. Oncogene 2001;20:5378-92.
56. Chernova OB, Somerville RP, Cowell JK. A novel gene, LGI1, from 10q24 is rearranged and downregulated in malignant brain tumors. Oncogene 1998;17:2873-81.